HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

5- (4- butoxy- 3- chlorophenyl)- N- ((2- morpholinopyridin- 3- yl)methyl)nicotinamide

a Na(v)1.8 sodium channel blocker; structure in first source

Also Known As:

A 887826; A-887826; A887826

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Heterocyclic Compounds: 198
- 1-Ring Heterocyclic Compounds
  - Pyridines: 88
    - Nicotinic Acids: 13
      - Niacinamide: 2223
        5-(4-butoxy-3-chlorophenyl)-N-((2-morpholinopyridin-3-yl)methyl)nicotinamide: 1
  - Oxazines: 9
    - Morpholines: 6
      - 5-(4-butoxy-3-chlorophenyl)-N-((2-morpholinopyridin-3-yl)methyl)nicotinamide: 1
- Heterocyclic Acids
  - Nicotinic Acids: 13
    - Niacinamide: 2223
      - 5-(4-butoxy-3-chlorophenyl)-N-((2-morpholinopyridin-3-yl)methyl)nicotinamide: 1

Experts

1.	Atkinson, Robert N: 1 article (09/2010)
2.	Chapman, Mark L: 1 article (09/2010)
3.	Faltynek, Connie R: 1 article (09/2010)
4.	Hakeem, Ahmed H: 1 article (09/2010)
5.	Honore, Prisca: 1 article (09/2010)
6.	Jarvis, Michael F: 1 article (09/2010)
7.	Joshi, Shailen: 1 article (09/2010)
8.	Kort, Michael E: 1 article (09/2010)
9.	Krafte, Douglas S: 1 article (09/2010)
10.	Marron, Brian E: 1 article (09/2010)

Related Diseases

1.	Neuralgia (Stump Neuralgia) 09/01/2010 - "Following oral administration, A-887826 significantly attenuated tactile allodynia in a rat neuropathic pain model. "
2.	Hyperalgesia 09/01/2010 - "A-887826 is a structurally novel, potent and voltage-dependent Na(v)1.8 sodium channel blocker that attenuates neuropathic tactile allodynia in rats." 09/01/2010 - "Following oral administration, A-887826 significantly attenuated tactile allodynia in a rat neuropathic pain model. "

Related Drugs and Biologics

1.	Sodium Channel Blockers

Related Therapies and Procedures

1.	Oral Administration